Skip to main content
Clinical Trials/IRCT2015092624209N1
IRCT2015092624209N1
Completed
Phase 2

Investigating the effectiveness of methylphenidate and combination of magnesium and zinc and calcium in treatment of symptoms of attention deficit hyperactivity disorder (ADHD) among 6 to 12 children suffered from ADHD in Zahedan city

Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser
Enrollment
40
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser

Eligibility Criteria

Inclusion Criteria

  • Aged 6 to 12 years; diagnosis of attention deficit hyperactivity disorder (ADHD) based on DSM\-IV\-TR diagnostic criteria; the scale to measure attention deficit hyperactivity disorder (ADHD) in parent and teacher form, at least 20\.
  • Exclusion criteria: Any simultaneous major psychiatric disease, except confrontational behavior and learning disorder; IQ less than 70; the use of psychotropic drugs or narcotic materials in the past two weeks; any important neurological diseases; taking any drug affecting the nervous system, at least two weeks prior to the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials